Associated Papers
The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS.
Dzhashiashvili Y et al.
Neurobiology of Disease, 2019
Expression of a Mutant SEMA3A Protein with Diminished Signalling Capacity Does Not Alter ALS-Related Motor Decline, or Confer Changes in NMJ Plasticity after BotoxA-Induced Paralysis of Male Gastrocnemic Muscle.
Moloney EB et al.
Plos One, 2017
Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
Avossa D et al.
Neuroscience, 2006
Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS.
Alexander GM et al.
Brain Research. Molecular Brain Research, 2004
Select a paper to view details